Clinical Trial Update: Whole Blood Bactericidal Activity (WBA) Against Mycobacterium Tuberculosis of Faropenem Plus Amoxicillin/Clavulanic Acid in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial in healthy volunteers evaluating the whole blood bactericidal activity of a combination of faropenem and amoxicillin/clavulanic acid against Mycob…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Amoxicillin/clavulanic acid (amoxicillin/clavulanic acid)
• Faropenem (faropenem)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED